Concepedia

Author

Betty Chang

Pharmacyclics (United States)ORCID

Also Known As

B Chang, B Y Chang, B. Chang, Benedict Chang, Betty Chang, Betty Y Chang, Betty Y. Chang, Chang B

193

Publications

20.9K

Citations

46

H-Index

81

Concepts

All Affiliations

Pharmacyclics (United States)The University of Texas MD Anderson Cancer CenterStanford UniversityCornell UniversityThe Ohio State University
BC

About

Betty Chang is an author at Pharmacyclics (United States) specializing in medicine, cell biology, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

22

7.9K

2

Health Sciences

5

5

910

3

Natural Sciences

4

4

2.2K

4

Allergy

1

1

62

5

Biology

1

1

22

Betty Chang

×

62

Publications

20.7K

Citations

45

H-Index

YearCitations

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré,

New England Journal of Medicine

2013

2.2K

A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology

David J. Pagliarini, Sarah E. Calvo, Betty Chang,

Cell

2008

2K

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin,

New England Journal of Medicine

2013

1.7K

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Lee Honigberg, Ashley M. Smith, Mint Sirisawad,

Proceedings of the National Academy of Sciences

2010

1.5K

Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib

Jennifer A. Woyach, Richard R. Furman, Ta-Ming Liu,

New England Journal of Medicine

2014

1.2K

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

Ranjana H. Advani, Joseph J. Buggy, Jeff P. Sharman,

Journal of Clinical Oncology

2012

1.1K

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

Wyndham H. Wilson, Ryan M. Young, Roland Schmitz,

Nature Medicine

2015

1.1K

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan,

Blood

2013

783

Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome

Xonia Carvajal‐Vergara, Ana Sevilla, Sunita L. D’Souza,

Nature

2010

695

Wdr5 Mediates Self-Renewal and Reprogramming via the Embryonic Stem Cell Core Transcriptional Network

Yen-Sin Ang, Su‐Yi Tsai, Dung‐Fang Lee,

Cell

2011

550

Page 1